News & Events
2025 ASCO Annual Meeting
1Cell.Ai at ASCO 2025: Explore Our Latest Research We’re excited to share 19 new posters and abstracts at the 2025 ASCO Annual Meeting. Our latest findings highlight the power of single-cell, live-cell, and ctDNA analysis
AACR 2025 – Advancing Single-Cell Precision
We’re excited to share our latest research on true live single circulating tumor cell (CTC) capture with zero leukocyte contamination, enabling accurate multi-omic profiling across large cancer patient populations. This breakthrough supports more precise, real-time
1Cell.Ai: A Legacy of Innovation in Liquid Biopsy & Precision Oncology
We’ve contributed over 40+ publications—from ASCO to ESMO—highlighting advances in circulating tumor cells (CTCs), ctDNA, and AI-powered cancer diagnostics. Explore our collection of peer-reviewed studies, posters, and abstracts across: From foundational research to clinical applications,
1Cell.Ai Featured in the Journal of Liquid Biopsy
Advancing the Science of ctDNA and CTC-Based Diagnostics Across Cancer Types We’re proud to be featured in five recent publications in the Journal of Liquid Biopsy, the official journal of the International Society of Liquid
Single-Cell Genomics Reveals Resistance Signatures in Colorectal Cancer
Presented at ESMO Congress 2024 – Barcelona, Spain This abstract highlights how true single-circulating tumor cell (CTC) genomics can identify enriched therapy-resistance signatures in advanced colorectal cancer patients. The findings underscore the potential of single-cell
